Bureau Veritas refocuses its portfolio in line with its LEAP | 28 strategy and enters into an agreement to sell its Food testing business to Mérieux NutriSciences
October 07 2024 - 12:30AM
Business Wire
Bureau Veritas, a global leader in Testing,
Inspection, and Certification services, announced today that it has
entered into an agreement to sell its Food testing business (EUR
133 million in revenue in 2023) to Mérieux NutriSciences for an
Enterprise Value of EUR 360 million and net proceeds from disposals
of around EUR 290 million. This divestment reflects the Group’s
active portfolio management, in line with Bureau Veritas’ LEAP | 28
strategy. The Group aims to focus its portfolio on served markets
where it targets top leadership and performance positions by
2028.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20241006170537/en/
Hinda Gharbi, CEO Bureau Veritas (Photo:
Business Wire)
The food testing business is a laboratory activity serving
customers in the food sector. Services include microbiology testing
and chemical analysis, amongst others. It operates a global network
of 34 laboratories across the Americas, Africa, Asia and the
Pacific, and employs over 1,900 technical staff, including chemists
and microbiologists.
After closing, transaction proceeds will finance the accelerated
M&A plans of the LEAP I 28 strategy. This operation will
slightly enhance the Group's adjusted operating margin and is
neutral on the attributable adjusted net profit as of 2025.
“This divestment demonstrates our active portfolio management,
in line with the Focused Portfolio pillar of our strategic plan.
The transaction strengthens our balance sheet and gives us greater
leeway to implement our ambitious acquisition plan. We are pleased
to partner with Mérieux NutriSciences, a leader in Food testing,
whose global footprint and proven expertise is the perfect fit for
our food business and would allow it to thrive and to contribute to
make food systems safer, healthier and more sustainable,” said
Hinda Gharbi, Chief Executive Officer of Bureau Veritas.
“The acquisition of Bureau Veritas' Food testing business marks
a pivotal milestone for Mérieux NutriSciences. This will
significantly expand our geographic coverage, consolidating a
strong presence on every continent, enhancing our ability to serve
customers, and ultimately increasing our contribution to the
safety, quality, and sustainability of global food systems. After
closing of the transaction, together with the 1,900 future
colleagues joining us from Bureau Veritas, we will be even stronger
in fulfilling our purpose: 'Better Food. Better Health. Better
World,'” added Nicolas Cartier, Chief Executive Officer of
Mérieux NutriSciences.
The transaction is expected to close by the end of the fourth
quarter of 2024, once customary closing conditions have been met,
including regulatory clearance in certain geographies.
***
About Bureau Veritas
Bureau Veritas is a world leader in inspection, certification,
and laboratory testing services with a powerful purpose: to shape a
world of trust by ensuring responsible progress. With a vision to
be the preferred partner for its customers’ excellence and
sustainability, the company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 83,000 employees deliver services
in 140 countries. The company’s technical experts support customers
to address challenges in quality, health and safety, environmental
protection, and sustainability. Bureau Veritas is listed on
Euronext Paris and belongs to the CAC 40 ESG, CAC Next 20, SBF 120
indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN
code FR 0006174348, stock symbol: BVI. For more information, visit
www.bureauveritas.com, and follow us on LinkedIn.
Our information is certified with blockchain technology. Check
that this press release is genuine at www.wiztrust.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241006170537/en/
ANALYST/INVESTOR CONTACTS
Laurent Brunelle +33 (0)1 55 24 76 09
laurent.brunelle@bureauveritas.com
Colin Verbrugghe +33 (0)1 55 24 77 80
colin.verbrugghe@bureauveritas.com
Karine Ansart +33 (0)1 55 24 76 19
karine.ansart@bureauveritas.com
MEDIA CONTACTS
Anette Rey +33 (0)6 69 79 84 88
anette.rey@bureauveritas.com
Martin Bovo +33 (0) 6 14 46 79 94
martin.bovo@bureauveritas.com
Bureau Veritas (EU:BVI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Bureau Veritas (EU:BVI)
Historical Stock Chart
From Nov 2023 to Nov 2024